Publications:158
Weiva Sieh, MD, PhD, MS
About Me
Dr. Sieh’s research focuses on identifying genetic and epidemiologic factors underlying cancer susceptibility and outcomes. Current interests include:
1) Genetic and environmental determinants of mammographic breast density; relationship of breast density and other image features to breast cancer risk.
2) Genomic risk prediction using machine learning methods.
3) Risk and prognosis of hormone-related cancers, including cancers of the breast, ovary and prostate.
Language
Position
About Me
Dr. Sieh’s research focuses on identifying genetic and epidemiologic factors underlying cancer susceptibility and outcomes. Current interests include:
1) Genetic and environmental determinants of mammographic breast density; relationship of breast density and other image features to breast cancer risk.
2) Genomic risk prediction using machine learning methods.
3) Risk and prognosis of hormone-related cancers, including cancers of the breast, ovary and prostate.
Language
Position
Education
BA Biology, Harvard University
MD Medicine, McGill University
MS Biostatistics, University of Washington
PhD Epidemiology, University of Washington
Postdoc Statistical Genetics, University of Washington
Locations
Publications
Selected Publications
- Ovarian cancer risk and survival according to tumor sex hormone receptor expression: An ovarian Cancer association consortium and ovarian tumor tissue analysis consortium pooled analysis. Zhuxuan Fu, Lauren Borho, Sarah E. Taylor, Linda E. Kelemen, Anna DeFazio, Penelope M. Webb, Martin Köbel, Nicola S. Meagher, Renhua Na, Antonis C. Antoniou, Alison H. Brand, Catherine J. Kennedy, Nikilyn Nevins, Paul D.P. Pharoah, Yurii B. Shvetsov, Stacey J. Winham, Jennifer Alsop, Matthias W. Beckmann, Adelyn Bolithon, Jessica Boros, David D.L. Bowtell, James D. Brenton, Michael E. Carney, Anita Chudecka-Głaz, Linda S. Cook, Cezary Cybulski, Peter A. Fasching, Sian Fereday, Renée T. Fortner, María J. García, Ellen L. Goode, Marc T. Goodman, Jacek Gronwald, Arndt Hartmann, Brenda Y. Hernandez, Estrid Høgdall, David G. Huntsman, Allan Jensen, Mercedes Jimenez-Linan, Janine M. Joseph, Beth Y. Karlan, Ewa Kaznowska, Susanne K. Kjaer, Tomasz Kluz, Jennifer M. Koziak, Jenny Lester, Teri A. Longacre, Maria Lycke, Valerie McGuire, Kirsten B. Moysich, Rachel A. Murphy, Sandra Orsulic, Susan J. Ramus, Cristina Rodríguez-Antona, Joseph H. Rothstein, Spinder Samra, Weiva Sieh, Helen Steed, Karin Sundfeldt, Aline Talhouk, Jan Uciński, Chen Wang, Nicolas Wentzensen, Alice S. Whittemore, Lynne R. Wilkens, Thomas Songer, Maria Mori Brooks, Lu Tang, Francesmary Modugno. Gynecologic Oncology
- Diet and survival after a diagnosis of ovarian cancer: a pooled analysis from the Ovarian Cancer Association Consortium. Christina M. Nagle, Torukiri I. Ibiebele, Renhua Na, Elisa V. Bandera, Daniel Cramer, Jennifer A. Doherty, Graham G. Giles, Marc T. Goodman, Gillian E. Hanley, Holly R. Harris, Allan Jensen, Susanne K. Kjaer, Alice Lee, Valerie McGuire, Roger L. Milne, Bo Qin, Jean Richardson, Naoko Sasamoto, Joellen M. Schildkraut, Weiva Sieh, Kathryn L. Terry, Linda Titus, Britton Trabert, Nicolas Wentzensen, Anna H. Wu, Andrew Berchuck, Malcolm C. Pike, Celeste Leigh Pearce, Penelope M. Webb. American Journal of Clinical Nutrition
- Vitamin D-related genetic variants and prostate cancer risk in Black men. Tracy M. Layne, Joseph H. Rothstein, Xiaoyu Song, Shaneda Warren Andersen, Emma K.T. Benn, Weiva Sieh, Robert J. Klein. Cancer Epidemiology
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Sieh did not report having any of the following types of financial relationships with industry and other outside entities during 2024 and/or 2025: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Sieh did not report having any of the following types of financial relationships with industry and other outside entities during 2024 and/or 2025: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.